#BEGIN_DRUGCARD DB04482

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C17H26N3O15P

# Chemical_IUPAC_Name:
(2R,4R,5S,6R)-2-[({[(2S,3R,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-6-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyoxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cmp-2-Keto-3-Deoxy-Octulosonic Acid

# HET_ID:
CMK

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C17H26N3O15P/c18-9-1-2-20(16(29)19-9)14-12(26)11(25)8(33-14)5-32-36(30,31)35-17(15(27)28)3-6(22)10(24)13(34-17)7(23)4-21/h1-2,6-8,10-14,21-26H,3-5H2,(H,27,28)(H,30,31)(H2,18,19,29)/t6-,7+,8+,10+,11+,12-,13-,14-,17-/m1/s1

# InChI_Key:
InChIKey=YWWJKULNWGRYAS-QBDUXVKASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4482

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
543.3732

# Molecular_Weight_Mono:
543.110153689

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GQC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.8

# Predicted_LogS:
-1

# Predicted_Water_Solubility:
4.96e+01 g/l

# Primary_Accession_No:
DB04482

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936984

# PubChem_Substance_ID:
46506999

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00957

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC(=O)N(C=C1)[C@@H]1O[C@@H](CO[P@](O)(=O)O[C@]2(C[C@@H](O)[C@H](O)[C@H](O2)[C@@H](O)CO)C(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:22 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L42023

# Drug_Target_1_GenBank_ID_Protein:
1573006

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
kdsB

# Drug_Target_1_Gene_Sequence:
>765 bp
TTAATTCGCCGCTAAAATTGCCCGCACTTTTTCCAAATCTTCGGCGGTATCCACCCCCAC
TGCAGGCACTTCTTTCGCAAGTTCTACGTGAATACGTTCGCCGTTATATAACACACGAAG
CTGCTCAAGTTTTTCTAGATTTTCAAGTTGAGTCGGTGCCCATTGCACATATTGTTTTAT
GAAACCCGCACGATATGCGTAAATGCCAATATGACGTAAGTAAGCGTCAGAAAGCTGTAC
TTTCTGAACATCCTGCAAATTCATAAACTGATCACGATCATAAGGAATAACCGAACGGGA
AAAATACAGCACATAGCCATCTTTATCTGTTAATACTTTCACTGCATTTGGATTAAATAA
TTCCTCAGCATCGTGAATTTTTACCGCAAGGCTTGCCATATTGACATTAAATTTTGCTAA
ATTATCTGCCACTTGTCGCACGATAACGGGAGGAATCAAAGGCTCATCGCCTTGAATATT
GACAATGATTTCATTGTCAGGAATAGCTAATTTTTCTACAACTTCTGCTAAACGTTCTGT
ACCAGAATTATGATTAACCGAAGTCATACAGACTTCAGCACCAAAACTTTTGGCAACATC
AGCCACATTTTCATTATCGGTGGCAATAATCACTCGGCTCGCCCCAGACTGCAGTGCTTT
CTCAAATACATGTTGAATCATTGGCTTACCTTTAATATCAGCAAGAGGTTTTCCTGGCAA
ACGACTTGATGCAAAACGAGCGGGGATAATCACGGTAAATGACAT

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
7542800	Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al.: Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science. 1995 Jul 28;269(5223):496-512.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3120

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
28256

# Drug_Target_1_Name:
3-deoxy-manno-octulosonate cytidylyltransferase

# Drug_Target_1_Number_of_Residues:
254

# Drug_Target_1_PDB_ID:
1VIC

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_1_Protein_Sequence:
>3-deoxy-manno-octulosonate cytidylyltransferase
MSFTVIIPARFASSRLPGKPLADIKGKPMIQHVFEKALQSGASRVIIATDNENVADVAKS
FGAEVCMTSVNHNSGTERLAEVVEKLAIPDNEIIVNIQGDEPLIPPVIVRQVADNLAKFN
VNMASLAVKIHDAEELFNPNAVKVLTDKDGYVLYFSRSVIPYDRDQFMNLQDVQKVQLSD
AYLRHIGIYAYRAGFIKQYVQWAPTQLENLEKLEQLRVLYNGERIHVELAKEVPAVGVDT
AEDLEKVRAILAAN

# Drug_Target_1_Reaction:
CTP + 3-deoxy-D-manno-octulosonate = diphosphate + CMP-3-deoxy-D-manno-octulosonate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Activates KDO (a required 8-carbon sugar) for incorporation into bacterial lipopolysaccharide in Gram-negative bacteria

# Drug_Target_1_SwissProt_ID:
P44490

# Drug_Target_1_SwissProt_Name:
KDSB_HAEIN

# Drug_Target_1_Synonyms:
CKS
CMP-2-keto-3-deoxyoctulosonic acid synthetase
CMP-KDO synthetase
EC 2.7.7.38

# Drug_Target_1_Theoretical_pI:
5.39

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X74567

# Drug_Target_2_GenBank_ID_Protein:
397407

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
kpsU

# Drug_Target_2_Gene_Sequence:
>741 bp
ATGAGCAAAGCAGTTATTGTCATTCCGGCTCGCTATGGCTCCTCGCGCCTGCCGGGTAAG
CCACTGCTCGATATTGTTGGTAAACCGATGATCCAGCATGTTTACGAGCGTGCGTTACAG
GTGGCGGGCGTTGCGGAAGTTTGGGTGGCAACAGACGATCCGCGTGTTGAACAGGCCGTA
CAGGCGTTTGGCGGGAAAGCCATCATGACGCGCAACGATCATGAATCCGGCACCGATCGG
CTGGTCGAGGTGATGCATAAAGTCGAGGCAGATATCTACATTAACCTGCAGGGCGACGAA
CCAATGATTCGCCCGCGGGATGTAGAAACGCTGCTACAAGGAATGCGTGACGATCCCGCG
TTGCCGGTGGCAACGCTATGCCACGCGATTTCTGCCGCAGAAGCGGCTGAGCCAAGCACG
GTAAAAGTGGTTGTGAATACCCGCCAGGATGCGCTTTATTTCAGCCGCTCACCGATTCCG
TATCCGCGTAATGCTGAAAAAGCGCGCTACCTGAAACACGTCGGTATTTACGCTTATCGT
CGCGATGTGCTGCAAAACTACAGCCAGTTACCGGAGTCCATGCCGGAGCAGGCGGAATCA
CTGGAGCAGCTAAGGTTGATGAACGCGGGGATCAACATCCGCACATTTGAGGTTGCCGCA
ACCGGTCCGGGCGTCGACACCCCAGCATGCCTGGAAAAAGTGCGCGCCCTGATGGCACAG
GAACTGGCTGAAAACGCATGA

# Drug_Target_2_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_2_General_References:
7875563	Rosenow C, Roberts IS, Jann K: Isolation from recombinant Escherichia coli and characterization of CMP-Kdo synthetase, involved in the expression of the capsular K5 polysaccharide (K-CKS). FEMS Microbiol Lett. 1995 Jan 15;125(2-3):159-64.
8397187	Pazzani C, Rosenow C, Boulnois GJ, Bronner D, Jann K, Roberts IS: Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide. J Bacteriol. 1993 Sep;175(18):5978-83.
8706906	Jelakovic S, Jann K, Schulz GE: The three-dimensional structure of capsule-specific CMP: 2-keto-3-deoxy-manno-octonic acid synthetase from Escherichia coli. FEBS Lett. 1996 Aug 5;391(1-2):157-61.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2765

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
27159

# Drug_Target_2_Name:
3-deoxy-manno-octulosonate cytidylyltransferase

# Drug_Target_2_Number_of_Residues:
246

# Drug_Target_2_PDB_ID:
1GQC

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_2_Protein_Sequence:
>3-deoxy-manno-octulosonate cytidylyltransferase
MSKAVIVIPARYGSSRLPGKPLLDIVGKPMIQHVYERALQVAGVAEVWVATDDPRVEQAV
QAFGGKAIMTRNDHESGTDRLVEVMHKVEADIYINLQGDEPMIRPRDVETLLQGMRDDPA
LPVATLCHAISAAEAAEPSTVKVVVNTRQDALYFSRSPIPYPRNAEKARYLKHVGIYAYR
RDVLQNYSQLPESMPEQAESLEQLRLMNAGINIRTFEVAATGPGVDTPACLEKVRALMAQ
ELAENA

# Drug_Target_2_Reaction:
CTP + 3-deoxy-D-manno-octulosonate = diphosphate + CMP-3-deoxy-D-manno-octulosonate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Activates KDO (a required 8-carbon sugar) for incorporation into bacterial lipopolysaccharide in Gram-negative bacteria

# Drug_Target_2_SwissProt_ID:
P42216

# Drug_Target_2_SwissProt_Name:
KPSU5_ECOLX

# Drug_Target_2_Synonyms:
CKS
CMP-2-keto-3-deoxyoctulosonic acid synthetase
CMP-KDO synthetase
EC 2.7.7.38

# Drug_Target_2_Theoretical_pI:
5.70

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04482
